World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
74
Citations
18593
World Ranking
19445
National Ranking
783

Overview

Francesco Bertolini is affiliated with the European Institute of Oncology in Italy and primarily conducts research within the fields of Medicine and Biochemistry, Genetics and Molecular Biology.

The scientist's work covers several subfields, including:

  • Oncology
  • Immunology
  • Molecular Biology
  • Genetics
  • Hematology

Research by Bertolini engages with a range of topics, with a particular focus on:

  • Immune Cell Function and Interaction
  • Cancer Genomics and Diagnostics
  • Cancer Immunotherapy and Biomarkers
  • Acute Myeloid Leukemia Research
  • CAR-T cell therapy research
  • Immune cells in cancer
  • Single-cell and spatial transcriptomics

Recent publications include:

  • "Archaeogenomic distinctiveness of the Isthmo-Colombian area" (2021, Cell)
  • "Red cell-bound antibodies and transfusion requirements in hospitalized patients with COVID-19" (2020, Blood)
  • "Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects" (2022, Cell Reports)
  • "Cyclophosphamide and Vinorelbine Activate Stem-Like CD8+ T Cells and Improve Anti-PD-1 Efficacy in Triple-Negative Breast Cancer" (2020, Cancer Research)
  • "Circulating endothelial progenitors are increased in COVID-19 patients and correlate with SARS-CoV-2 RNA in severe cases" (2020, Journal of Thrombosis and Haemostasis)

Bertolini frequently collaborates with coauthors such as:

  • Paolo Falvo
  • Stefania Orecchioni
  • Alessandro Raveane
  • Giulia Mitola
  • Giovanna Talarico

The scientist's work has been published in several venues, with notable frequency in:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Blood
  • Cancers
  • Research Square

Best Publications

  • The multifaceted circulating endothelial cell in cancer: towards marker and target identification

    Francesco Bertolini;Yuval Shaked;Patrizia Mancuso;Robert S. Kerbel

  • Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells.

    Francesco Bertolini;Saki Paul;Patrizia Mancuso;Silvia Monestiroli

  • Circulating endothelial cells Biomarker of vascular disease

    Andrew D. Blann;Alexander Woywodt;Francesco Bertolini;Todd M. Bull

  • Resting and activated endothelial cells are increased in the peripheral blood of cancer patients

    Patrizia Mancuso;Alessandra Burlini;Giancarlo Pruneri;Aron Goldhirsch

  • Rapid Chemotherapy-Induced Acute Endothelial Progenitor Cell Mobilization: Implications for Antiangiogenic Drugs as Chemosensitizing Agents

    Yuval Shaked;Erik Henke;Jeanine M.L. Roodhart;Patrizia Mancuso

  • Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

    Filiberto Belli;Alessandro Testori;Licia Rivoltini;Michele Maio

  • Genetic heterogeneity of the vasculogenic phenotype parallels angiogenesis: Implications for cellular surrogate marker analysis of antiangiogenesis

    Yuval Shaked;Francesco Bertolini;Shan Man;Michael S. Rogers

  • Angiogenesis in myelodysplastic syndromes.

    G Pruneri;F Bertolini;D Soligo;N Carboni

  • Metronomic Cyclophosphamide and Capecitabine Combined With Bevacizumab in Advanced Breast Cancer

    Silvia Dellapasqua;Francesco Bertolini;Vincenzo Bagnardi;Elisabetta Campagnoli

  • Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity.

    Yuval Shaked;Urban Emmenegger;Urban Emmenegger;Shan Man;Shan Man;Dave Cervi;Dave Cervi

  • Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy

    Patrizia Mancuso;Marco Colleoni;Marco Colleoni;Angelica Calleri;Angelica Calleri;Laura Orlando;Laura Orlando

  • CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma

    Francesco Bertolini;Chiara Dell'Agnola;Patrizia Mancuso;Cristina Rabascio

  • Drug repurposing in oncology—patient and health systems opportunities

    Francesco Bertolini;Vikas P. Sukhatme;Gauthier Bouche

  • Locoregional recurrence risk after lipofilling in breast cancer patients

    J.Y. Petit;E. Botteri;V. Lohsiriwat;M. Rietjens

  • Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial

    C Bengala;F Bertolini;N Malavasi;C Boni

  • Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.

    Alice Agliano;Ines Martin-Padura;Patrizia Mancuso;Paola Marighetti

  • Evaluation of fat grafting safety in patients with intra epithelial neoplasia: a matched-cohort study

    J.Y. Petit;M. Rietjens;E. Botteri;N. Rotmensz

  • Kinetics and viability of circulating endothelial cells as surrogate angiogenesis marker in an animal model of human lymphoma.

    Silvia Monestiroli;Patrizia Mancuso;Alessandra Burlini;Giancarlo Pruneri

  • Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients

    Francesco Bertolini;Manuela Battaglia;Paolo Pedrazzoli;Gian Antonio Da Prada

  • In Vitro Assessment of the Quality of Stored Platelet Concentrates

    Scott Murphy;Paulo Rebulla;Francesco Bertolini;Stein Holme

Frequent Co-Authors

Giovanni Martinelli
Giovanni Martinelli University of Bologna
Giancarlo Pruneri
Giancarlo Pruneri University of Milan
Robert S. Kerbel
Robert S. Kerbel University of Toronto
Giuseppe Curigliano
Giuseppe Curigliano University of Milan
Giuseppe Viale
Giuseppe Viale University of Milan
Vincenzo Bagnardi
Vincenzo Bagnardi University of Milano-Bicocca
Aron Goldhirsch
Aron Goldhirsch European Institute of Oncology
Antonino Neri
Antonino Neri University of Milan
Marco Colleoni
Marco Colleoni European Institute of Oncology
Pier Giuseppe Pelicci
Pier Giuseppe Pelicci European Institute of Oncology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens the door to a range of related healthcare programs and career paths. For registered nurses aiming to advance their role and expand their scope, adn to fnp programs provide an effective bridge from associate-level training to becoming a Family Nurse Practitioner.

Those interested in public health, wellness, and preventative care might consider online nutrition degree programs. These flexible options prepare graduates for careers in nutrition, dietetics, and health coaching.

Healthcare professionals focused on administration and leadership can enhance their qualifications through online mha programs cahme accredited. These degrees are ideal for climbing the management ladder within hospitals and healthcare organizations.

Additionally, RNs who want to earn a bachelor’s degree without the traditional hands-on requirements can enroll in rn to bsn online without clinicals programs. This pathway offers greater accessibility for working nurses.

Each of these online programs provides unique opportunities to specialize, advance your career, and make an impact in the evolving healthcare sector.

Best Scientists Citing Francesco Bertolini

Trending Scientists

Recently Published Articles